Monday , October 23 2017
Home / Letter From The Editor / Letter from the Editor, #748

Letter from the Editor, #748

For the past 18 months we have been providing you with a monthly newsletter with special features focused on GLP-1 analogs. These newsletters have provided information beginning with the first discovery of GLP-1 and GIP in the body and how they worked to control glucose levels, and have included practice experience from your colleagues and other thought leaders. We have also been able to provide you some of the best Homerun Slides for you to use.

Now that the class has grown from first-in-class "Byetta" to include five unique compounds, we just released a great handout on the features and differences of each one, and just when I thought that we had covered about everything there was going on, our interns found four new studies and one new fact from the recently completed EASD meeting for you to review.

While you’re looking at those GLP-1 slides you may want to check out the Homerun Slides series by Dr. Stanley Schwartz and learn why and how his aggressive methods of treating diabetes almost always include a GLP-1 analog

*****

Announcements:
 
With a day packed full of education, motivational tools, one-on-one sessions, and workshops, the TCOYD health fair is a great way to get your patients to take better care of their health and themselves. TCOYD.com 
 
From dLife.com: "One of the country’s largest health organizations conducts a groundbreaking study on how media can improve diabetes control. Also, a savory soup from the dLife kitchen, and another extreme diabetes makeover." Sundays live online at dLifeTV.com at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at dLifeTV.com.
 
*****************************

We can make a difference!
*****************************

Dave Joffe, Editor-in-chief